Jindal Saw Q1 FY27 Earnings Call Transcript Released
Jindal Saw reported Q1 FY27 results with standalone income at ₹3,756 crore (up 13%) but PAT down 70% to ₹110 crore. Consolidated income was ₹4,476 crore (up 9%) with PAT down 78% to ₹91 crore. Operations were impacted by geopolitical issues and API license suspension. New projects in UAE and Saudi Arabia are underway, with commercial operations expected from FY29.
The announcement details significant financial performance declines and operational challenges, directly impacting the company's profitability and future outlook. The discussion around geopolitical risks and project execution timelines also carries substantial weight for investors.
The financial results for Q1 FY27 show a significant decline in profitability (PAT) on both standalone and consolidated bases, despite revenue growth. This is primarily attributed to external factors like geopolitical issues in the MENA region and internal issues like the API license suspension, leading to muted operational performance.
Jindal Saw Limited has released the transcript of its conference call held on July 15, 2026, concerning the Un-audited (Standalone & Consolidated) financial results for the first quarter of FY27, ending June 30, 2026. The call was organized by ICICI Securities Limited for analysts and investors.
During the quarter, on a standalone basis, the company reported a total income of ₹3,756 crores, an increase of 13% from Q1 FY26. However, EBITDA declined by approximately 40% to ₹341 crores, PBT by 53% to ₹145 crores, and PAT by 70% to ₹110 crores.
On a consolidated basis, total income rose by approximately 9% to ₹4,476 crores. EBITDA saw a decline of about 39% to ₹421 crores, PBT fell by 60% to ₹148 crores, and PAT dropped by 78% to ₹91 crores.
The company's standalone net debt narrowed to ₹2,345 crores as of June 30, 2026. Consolidated net debt also reduced to ₹2,472 crores. CARE Ratings reaffirmed its ratings for both short-term and long-term debt facilities.
Operational performance in Q1 FY27 was muted due to factors including suspended outward shipments since March 2026 due to geopolitical situations in the MENA region, a weak domestic water segment impacted by delayed fund releases, and the temporary suspension of the API license for seamless pipes until mid-June 2026.
The company is actively pursuing new opportunities, including a seamless pipe manufacturing facility in Abu Dhabi with an estimated cost of USD 300 million, expected to commence commercial operations in FY29. Additionally, a joint venture in Saudi Arabia for LSAW and HSAW pipe mills is progressing, with interim financial closure expected in the coming months.
The subsidiary in UAE saw operations disrupted, with ductile iron pipe deliveries reduced. Jindal Hunting, a joint venture, incurred a loss of ₹5.3 crores in Q1 FY27, attributed to the suspension of Jindal Saw's API license.
Regarding future outlook, management anticipates that while Q2 may be similar to Q1, the second half of FY27 is expected to show improvements, assuming the geopolitical situation and domestic demand trends stabilize. The company is also exploring new markets to de-risk its order book geographically.
What to do with a filing like this
Jindal Saw Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jindal Saw Limited. Read the original for the full detail.